Latvian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
tuberculosis/protease
Saite tiek saglabāta starpliktuvē
10 rezultātiem
Prokaryotic proteasomal proteases of Mycobacterium tuberculosis (MTB) as targets for antibiotic therapy
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
FIELD OF THE INVENTION
The present invention relates to methods of treating pathogenic infection in mammals.
BACKGROUND OF THE INVENTION
About two billion people are thought to be infected with the bacillus Mycobacterium tuberculosis ("Mtb"), the causative agent of tuberculosis ("TB"). The majority
Mycobacterium membrane protease as a target for inhibitors of intrabacterial pH homeostasis
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
FIELD OF THE INVENTION
The present invention is directed to methods and compounds for inhibiting bacterial growth and treating a bacterial infection in a subject.
BACKGROUND OF THE INVENTION
When Metchnikoff discovered phagocytosis, he speculated that macrophages kill most ingested microbes by
Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
FIELD OF THE INVENTION
The present invention relates to compositions and methods for inhibition of bacterial infections comprising Gram negative, Gram positive, and acid fast bacilli in general and mycobacterium tuberculosis (TB), mycobacterium avium complex (MAC), and anthrax in particular, as well
Treatments for Mycobacterium tuberculosis
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
FIELD OF INVENTION
The invention relates to methods of treating Mycobacterium tuberculosis infections.
SEQUENCE LISTING
The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy,
Multivalent vaccines comprising recombinant viral vectors
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
TECHNICAL FIELD
The invention relates to the field of recombinant DNA and viral vector vaccines. Specifically, it relates to recombinant DNA and viral vectors harboring nucleic acids encoding multiple antigens and/or adjuvants.
BACKGROUND
Tuberculosis (TB) has been a major worldwide threat to human
Multivalent vaccines comprising recombinant viral vectors
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
JOINT RESEARCH AGREEMENT
The claimed invention was made by or on behalf of the following parties to a joint research agreement: Crucell Holland B.V. and Aeras Global TB Vaccine Foundation. The agreement was in effect on or before the date the claimed invention was made, and the claimed invention was
Multivalent vaccines comprising recombinant viral vectors
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
FIELD OF THE INVENTION
The invention relates to the field of recombinant DNA and viral vector vaccines. Specifically, it relates to recombinant DNA and viral vectors harboring nucleic acids encoding multiple antigens and/or adjuvants.
BACKGROUND OF THE INVENTION
Tuberculosis (TB) has been a major
Process for the enzymatic dispersal of Mycobacterium bovis - BCG
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
BACKGROUND OF THE INVENTION
Vaccines containing various living avirulent cells of tubercle bacilli, in particular Bacillus Calmette-Guerin (BCG), an attenuated bovine tuberculosis organism (Mycobacterium bovis), have been used to induce immunity against acquired tuberculosis disease in man.
Compositions of, and methods for, alpha-1 antitrypsin Fc fusion molecules
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
FIELD OF THE INVENTION
The present invention relates to compositions and methods for inhibition of bacterial infections comprising Gram negative, Gram positive, and acid fast bacilli in general and mycobacterium tuberculosis (TB), mycobacterium avium complex (MAC), and anthrax in particular, as well
Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
FIELD OF THE INVENTION
The present invention relates to compositions and methods for inhibition of bacterial infections comprising Gram negative, Gram positive, and acid fast bacilli in general and mycobacterium tuberculosis (TB), mycobacterium avium complex (MAC), and anthrax in particular, as well
Vispilnīgākā ārstniecības augu datu bāze, kuru atbalsta zinātne
- Darbojas 55 valodās
- Zāļu ārstniecības līdzekļi, kurus atbalsta zinātne
- Garšaugu atpazīšana pēc attēla
- Interaktīva GPS karte - atzīmējiet garšaugus atrašanās vietā (drīzumā)
- Lasiet zinātniskās publikācijas, kas saistītas ar jūsu meklēšanu
- Meklēt ārstniecības augus pēc to iedarbības
- Organizējiet savas intereses un sekojiet līdzi jaunumiem, klīniskajiem izmēģinājumiem un patentiem
Ierakstiet simptomu vai slimību un izlasiet par garšaugiem, kas varētu palīdzēt, ierakstiet zāli un redziet slimības un simptomus, pret kuriem tā tiek lietota.
* Visa informācija ir balstīta uz publicētiem zinātniskiem pētījumiem
